Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelley Lees

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Qualitative Health Research|July 5, 2023
Conducting Social Science Research During Epidemics and Pandemics: Lessons LearntJennifer I Van Nuil, Megan Schmidt-Sane, Alex Bowmer, et al.
Bulletin of the World Health Organization|October 8, 2021
Violence against children during the COVID-19 pandemicAmiya Bhatia, Camilla Fabbri, Ilan Cerna-Turoff, et al.
Vaccine|November 28, 2025
Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trialSusan A Kelly, John Changalucha, Donati Malibwa, et al.
PLOS Global Public Health|May 2, 2025
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the CongoHannah E Brindle, Darius Tetsa-Tata, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Tropical Medicine & International Health : TM & IH|April 3, 2025
Regulator experiences of trials during Ebola epidemics in Sierra Leone, Guinea, and the Democratic Republic of the CongoKambale Kasonia, Frank Baiden, Frédéric Le Marcis, et al.
Plos One|October 22, 2021
Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra LeoneLuisa Enria, Joseph S Bangura, Hassan M Kanu, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The New England Journal of Medicine|December 14, 2022
Randomized Trial of Vaccines for Zaire Ebola Virus Disease, Mark Kieh, Laura Richert, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Qualitative Health Research|July 5, 2023
Conducting Social Science Research During Epidemics and Pandemics: Lessons LearntJennifer I Van Nuil, Megan Schmidt-Sane, Alex Bowmer, et al.
Bulletin of the World Health Organization|October 8, 2021
Violence against children during the COVID-19 pandemicAmiya Bhatia, Camilla Fabbri, Ilan Cerna-Turoff, et al.
Vaccine|November 28, 2025
Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trialSusan A Kelly, John Changalucha, Donati Malibwa, et al.
PLOS Global Public Health|May 2, 2025
Using an analogue-digital hybrid clinical data management platform during a two-dose preventive Ebola virus vaccine trial in Goma, the Democratic Republic of the CongoHannah E Brindle, Darius Tetsa-Tata, Tansy Edwards, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Tropical Medicine & International Health : TM & IH|April 3, 2025
Regulator experiences of trials during Ebola epidemics in Sierra Leone, Guinea, and the Democratic Republic of the CongoKambale Kasonia, Frank Baiden, Frédéric Le Marcis, et al.
Plos One|October 22, 2021
Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra LeoneLuisa Enria, Joseph S Bangura, Hassan M Kanu, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The New England Journal of Medicine|December 14, 2022
Randomized Trial of Vaccines for Zaire Ebola Virus Disease, Mark Kieh, Laura Richert, et al.
Pageof 10